[1] |
ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie.
Adverse reaction monitoring of toothpaste in China under the new regulatory system
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222.
|
[2] |
YANG Minghan, QIAO Meiling, LUO Jiaoyang, YANG Meihua, SHENG Ping.
Acute toxicity of anti-gastric cancer active ingredients of Ferula ferulaeoides
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 880-884.
|
[3] |
SHEN Ningning, LIU Yufu, RU Yi, SHI Zhuo, YANG Chunqi, NI Zhexin, XIAO Chengrong, MA Zengchun, WANG Yuguang, GAO Yue.
Antifatigue effect of ophiopogonin D on exhaustive swimming in mice
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 749-753.
|
[4] |
WANG Rong, LIU Ziqun, WANG Nana, TAN Xiong, ZHANG Yixin, YANG Kuan, QIN Bei.
Acute toxicity of proline Danshensu borneol ester in mice
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 754-757.
|
[5] |
ZUO Zeping, TIAN Yingying, XU Yi, JIANG Kewu, YANG Shuo, YANG Hairun, ZHANG Zhicong, CAO Xinyao, WU Xiaoru, WANG Zhibin.
Preclinical safety evaluation of Jinkui Shenqi pills
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 775-782.
|
[6] |
ZHAO Wenhua, SHU He, NI Chenming, GUO Jinmin.
Data mining and analysis of adverse drug reaction signals of fampridine sustained-release tablets based on FAERS database
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 684-690.
|
[7] |
ZHU Lan, JIN Zhe, LIU Lihong, ZHONG Lumiao, LIUXiaojun.
Risks of Kangfuxiaoyan suppository due to routes of administration
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 306-310.
|
[8] |
ZHENG Chengcheng, WANG Huiping, XU Baihui, XU Jiaoyan, LI Beibei, ZHANG Xiaohong, ZHANG Wei, SUN Ying, WANG Enli.
Toxicity of Jingfang granule extract on embryo-fetal developmental of rats
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 493-497.
|
[9] |
ZHENG Chengcheng, XU Baihui, XU Jiaoyan, WANG Huiping, LI Beibei, ZHANG Xiaohong, SUN Ying, YAO Jingchun, WANG Enli.
Toxicity of Jingfang granule extract on perinatal rats
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 498-504.
|
[10] |
XU Baihui, WANG Enli, ZHENG Chengcheng, XU Jiaoyan, LI Beibei, ZHANG Xiaohong, ZHOU Zhongyi, WANG Yonggang, YAO Jingchun.
Toxicity of Jingfang granule extractum by 90 days repeated ingastric administration in rats
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 510-514.
|
[11] |
SHA Mingquan, LI Nannan, XIA Wenjing, WEI Qun, WEN Baoshu.
Research and reflection on regulatory science developments of U.S. FDA
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1055-1059.
|
[12] |
CHEN Ying, Wang Lijin, LI Liang, JIA Yanli, WANG Yu, LI Zike, WEI Na, HAN Gang, WU Chunqi, DONG Yansheng.
Evaluation of Psychological Dependency Potential of Dexmedetomidine in Rats in a Self-administration Study
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(9): 821-825.
|
[13] |
XIA Dongsheng, TIAN Chunhua, WANG Tao.
Changes of Drug Regulatory Concepts in Evidenced by Enactment and Revision of the Drug Administration Law
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(9): 837-844.
|
[14] |
WU Hao, ZHANG Bing, LIN Zhijian, ZHANG Xiaomeng.
Comparison of International Pharmacovigilance of Traditional Chinese Medicine and Natural Medicines
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(5): 406-410.
|
[15] |
DAI Biao, LIANG Jun, XIA Qingrong, XU Yayun, CAO Yin, WU Xiaoping.
Analysis of Splitting of Oral Tablets by Inpatients in a Psychiatric Hospital
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(4): 373-376.
|